临床与增强MRI特征机器学习模型鉴别脑结核瘤与肺癌脑转移
本研究开发并验证了一种整合临床与增强MRI特征的机器学习模型,用于无创鉴别脑结核瘤与肺癌脑转移。内部数据集188例(122例脑结核瘤,66例脑转移瘤),外部验证集51例(26例脑结核瘤,25例脑转移瘤)。多因素回归保留年龄、CEA、多发病变、环伴壁结节四个独立预测因子,Gradient Boosting模型在外部验证集AUC达0.957,敏感度88.0%,特异度92.3%。
要点
- 环伴壁结节是提示脑结核瘤的重要影像征象(OR=11.289)。
- 多发病变更倾向于肺癌脑转移(OR=0.080)。
- CEA升高支持肺癌脑转移诊断(OR=1.711)。
核心结论
- Gradient Boosting模型整合年龄、CEA、多发病变和环伴壁结节四个特征,可有效区分脑结核瘤与肺癌脑转移,外部验证AUC达0.957。
- 该模型提供了一种无创辅助临床决策的工具,有助于两种治疗策略完全不同的疾病鉴别。
研究设计与样本
- 研究类型为机器学习模型开发与验证,内部数据集188例(122例脑结核瘤,66例肺癌脑转移)。
- 内部数据按131例训练/验证集和57例内部测试集划分,特征选择仅在训练/验证集上进行。
- 外部测试集51例(26例脑结核瘤,25例脑转移瘤)来自另一家医院,用于独立验证。
- 采用单因素分析和逐步逻辑回归进行特征筛选,机器学习分类器使用重复5折交叉验证训练。
关键影像表现/征象
- 环伴壁结节是脑结核瘤的增强MRI特征性表现,多变量回归显示其OR为11.289。
- 多发病变在增强MRI上更常见于肺癌脑转移,OR为0.080。
诊断标准与关键数值
- 多因素逻辑回归保留的四个独立预测因子:年龄(OR=1.046,95%CI 1.003-1.091,p=0.036)、CEA(OR=1.711,95%CI 1.235-2.370,p=0.001)。
- 多发病变(OR=0.080,95%CI 0.015-0.438,p=0.004)、环伴壁结节(OR=11.289,95%CI 2.551-49.952,p=0.001)。
- Gradient Boosting模型内部测试集AUC为0.970(95%CI 0.925-0.998),外部测试集AUC为0.957(95%CI 0.900-0.995)。
- 外部测试集敏感度为88.0%,特异度为92.3%。
临床应用与阅片要点
- 日常阅片时发现脑内环形强化伴壁结节,应优先考虑脑结核瘤可能,而非肺癌脑转移。
- 多发病变且患者CEA升高时,应高度怀疑肺癌脑转移。
- 年龄是鉴别两者的独立预测因子之一,解读时需结合临床背景综合判断。
局限性
- 训练集与外部验证集样本量均较小,模型仍需更大样本进一步验证。
- 仅纳入肺癌脑转移作为对照,未涉及其他类型颅内环形强化病变的鉴别。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Cerebral tuberculomas (CTB) and lung cancer brain metastases (BM) frequently show overlapping appearances on conventional magnetic resonance imaging (MRI) but require entirely different treatment strategies. This study aimed to develop and validate a machine learning model integrating clinical and contrast-enhanced MRI features to noninvasively differentiate these two entities.
MATERIALS AND METHODS: The internal dataset (n = 188, 122 CTB, 66 BM) was split into training/validation (n = 131) and internal test (n = 57) sets. Feature selection (univariate and stepwise logistic regression) was performed only on the training and validation set, yielding four predictors. Machine learning classifiers were trained using these predictors with repeated 5-fold cross-validation. An external test set (n = 51, 26 CTB, 25 BM) from another hospital was used for independent validation.
RESULTS: Multivariate logistic regression retained four independent predictors: age (OR = 1.046, 95%CI: 1.003-1.091, p = 0.036), carcinoembryonic antigen (CEA) (odds ratios [OR] = 1.711, 95%confidence intervals [CI]: 1.235-2.370, p = 0.001), multiple lesions (OR = 0.080, 95%CI: 0.015-0.438, p = 0.004), and ring with mural nodule (OR = 11.289, 95%CI: 2.551-49.952, p = 0.001). The Gradient Boosting model built on these four features achieved the best performance, with an area under the receiver operating characteristic curve of 0.970 (95%CI: 0.925-0.998) on the internal test set and 0.957 (95%CI: 0.900-0.995) on the external test set. On the external test set, the model showed a sensitivity of 88.0% and a specificity of 92.3%.
CONCLUSION: A Gradient Boosting model integrating age, CEA, multiple lesions, and ring with mural nodule effectively distinguishes CTB from BM with robust external test performance, providing a noninvasive tool to assist clinical decision-making.
引用
- Wang, Dai, Chen, et al. Machine Learning Model Using Clinical and Contrast-Enhanced MRI Features Differentiates Cerebral Tuberculoma from Lung Cancer Brain Metastasis. Acad Radiol. 2026. PMID: 42907266. doi:10.1016/j.acra.2026.10.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。